Likarda is revolutionizing the delivery of cell therapies, biologics, and small molecules, making life-changing treatments more accessible for patients with chronic and life-threatening diseases. At its core is Core-Shell Spherification® (CSS®), a customizable polymer-based delivery platform designed to protect therapeutics, enable precise delivery, and retain them at their target—whether in the tumor microenvironment, sites of organ degeneration, or other critical areas. By enabling targeted, sustained release, CSS® enhances therapeutic efficacy, reduces off-target effects, and improves patient outcomes. Its versatility supports a range of applications, including immune protection in cell therapy and extended-release biologics, driving innovation in oncology, regenerative medicine, and beyond. With a focus on scalability, accessibility, and transformative drug delivery solutions, Likarda is advancing the next generation of therapeutics. Learn more at Likarda.com.